AMI Technologies Ltd. is a leading distributor of medical devices and innovative technology in Israel, with more than 30 years of experience. AMI Technologies’ portfolio comprises complementing products within the fields of intensive care & anaesthesia, cardio - thoracic surgery, interventional neuroradiology and interventional cardiology. AMI Technologies represents a number of well-known international brands and companies in the local market.

Rami Dulberg, Founder and Chairman of AMI Technologies Ltd., says “AMI Technologies Ltd enjoys a leadership position in all core medical products in the market. This outstanding market performance is based on the company’s clear and focused business strategy, the diversity and uniqueness of our product portfolio, as well as the professional competence and scientific approach shared by our people. We find QuickCool® SYSTEM most promising and it fits perfectly into our product portfolio comprising breakthrough technology and innovative products.”

”We have found the most optimum partner to represent QuickCool in Israel”, Fredrik Radencrantz, CEO at QuickCool, says. “We reviewed 5-6 potential distributors in Israel. After having met with Rami, we were convinced. AMI Technologies is our partner of choice in Israel. We will benefit from their vast experience, complementing product portfolio as well as their well-established sales, training and after sales support teams.“

AMI Technologies Ltd
AMI Technologies Ltd is a leading distributor of medical devices and innovative technology in Israel. The company was established by Rami Dulberg in 1986, and has been working within the medical industry for more than 30 years. AMI Technologies’ portfolio comprises complementing products within the fields of intensive care & anaesthesia, cardio - thoracic surgery, interventional neuroradiology and interventional cardiology.

For more information, please contact:
Fredrik Radencrantz, CEO
Phone: +46-46-286 38 40
E-mail: fredrik.radencrantz@quickcool.se

This information is such that QuickCool AB is required to make public in accordance with the EU’s market abuse regulation (MAR). The information was made publicly available by the Company’s contact person on 04 December 2018.

Quickcool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the Quickcool SYSTEM. Quickcool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. Quickcool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to: www.quickcool.se